ATRECA INC's ticker is BCEL and the CUSIP is 04965G109. A total of 53 filers reported holding ATRECA INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -73.3% | 1,600 | 0.0% | 0.00% | – |
| Q2 2023 | $1,568 | -14.0% | 1,600 | 0.0% | 0.00% | – |
| Q1 2023 | $1,824 | +42.4% | 1,600 | 0.0% | 0.00% | – |
| Q4 2022 | $1,281 | -57.3% | 1,600 | 0.0% | 0.00% | – |
| Q3 2022 | $3,000 | 0.0% | 1,600 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -40.0% | 1,600 | 0.0% | 0.00% | – |
| Q1 2022 | $5,000 | 0.0% | 1,600 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -50.0% | 1,600 | 0.0% | 0.00% | – |
| Q3 2021 | $10,000 | -28.6% | 1,600 | -5.9% | 0.00% | – |
| Q2 2021 | $14,000 | -46.2% | 1,700 | 0.0% | 0.00% | – |
| Q1 2021 | $26,000 | +73.3% | 1,700 | +88.9% | 0.00% | – |
| Q4 2020 | $15,000 | -40.0% | 900 | -50.0% | 0.00% | – |
| Q3 2020 | $25,000 | -58.3% | 1,800 | -35.7% | 0.00% | – |
| Q2 2020 | $60,000 | +30.4% | 2,800 | 0.0% | 0.00% | – |
| Q1 2020 | $46,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,320,880 | $2,100,000 | 1.66% |
| CM Management, LLC | 249,282 | $391,000 | 0.44% |
| Aisling Capital Management LP | 387,653 | $609,000 | 0.40% |
| Boxer Capital, LLC | 2,202,333 | $3,458,000 | 0.19% |
| Samsara BioCapital, LLC | 396,835 | $623,000 | 0.14% |
| Redmile Group, LLC | 800,306 | $1,256,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 191,442 | $301,000 | 0.04% |
| Baker Brothers Advisors | 3,532,760 | $5,546,000 | 0.04% |
| Cormorant Asset Management, LP | 319,057 | $501,000 | 0.04% |
| Rock Springs Capital Management LP | 462,530 | $726,000 | 0.02% |